Therefore, this study is the first of its kind to demonstrate the interaction between miR-134-5p and FOXP2 in trophoblast cell dysfunction and speculated at the development of targeted protocol for GDM treatment. The gene discussed is FOXP2; the disease is gestational diabetes.